Evidence map›Paper›PMID 15306824›Full record

ArticleLeukemia2004

The expression of immediate early gene X-1 (IEX-1) is differentially induced by retinoic acids in NB4 and KG1 cells: possible implication in the distinct phenotype of retinoic acid-responsive and -resistant leukemic cells.

A Arlt, J Minkenberg, B Kocs, M Grossmann, M-L Kruse, U R Fölsch, H Schäfer

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. YTHDF2-mediated mFrontiers in cellular and infection microbiology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Immediate early gene X-1 interacts with proteins that modulate apoptosis.Biochemical and biophysical research communications · 2004
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

A ArltDivision of Molecular Gastroenterology & Hepatology, 1st Department of Medicine, Christian-Albrechts-University, Kiel, Germany.
J Minkenberg
B Kocs
M Grossmann
M-L Kruse
U R Fölsch
H Schäfer
Kiel University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a cell-type- and stimulus-dependent fashion, the early response gene immediate early gene X-1 (IEX-1) is involved in growth control and modulation of apoptosis. The present study demonstrates that, in the two acute promyelocytic leukemia (APL) cell lines NB4 and KG1, exhibiting distinct responsiveness to retinoic acids (RAs), IEX-1 expression is rapidly (30-60 min) induced by all-trans- or cis-RA and independently of other signal transduction mediators, such as TNFalpha, NF-kappaB or MAP kinases. In NB4 cells (expressing PML-RARalpha), this increase is transient and completely reversible, along with a cell cycle arrest, ongoing differentiation and lower sensitivity to anti-cancer-drug-induced apoptosis. In contrast, the RA-induced IEX-1 expression in KG1 cells (expressing PLZF-RARalpha) persists over days, along with continued cell cycle progression and increased apoptotic sensitivity. Furthermore, two functional RA-response elements in the IEX-1 promoter were identified by gel shift and luciferase reporter gene assays. IEX-1 might be a rather unique transcriptional target of the two X-RARalpha fusion receptors exhibiting distinct responsiveness to RAs. Following a different time course of direct transcriptional induction by PML-RARalpha and PLZF-RARalpha in NB4 and KG1 cells, respectively, IEX-1 expression may be involved in the modified actions of these receptors and the distinct phenotypes of APL cells.

Indexed as

Drug Resistance, NeoplasmAntineoplastic AgentsApoptosisApoptosis Regulatory ProteinsCell CycleCell DifferentiationElectrophoretic Mobility Shift AssayGene Expression Regulation, LeukemicHumansImmediate-Early ProteinsLeukemia, Promyelocytic, AcuteLuciferasesMembrane ProteinsNeoplasm ProteinsOncogene Proteins, FusionPhenotypeAntineoplastic AgentsApoptosis Regulatory ProteinsIER3 protein, humanImmediate-Early ProteinsLuciferasesMembrane ProteinsNeoplasm ProteinsOncogene Proteins, FusionPLZF-RARalpha fusion protein, humanpromyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinTretinoin

Identifiers

PMID15306824
OpenAlexW2019714075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.